Neurocrine Biosciences Inc (NBIX)
134.73
-0.69
(-0.51%)
USD |
NASDAQ |
Dec 23, 11:25
Neurocrine Biosciences Profit Margin (Quarterly): 20.86% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Repligen Corp | -0.42% |
| West Pharmaceutical Services Inc | 18.21% |
| AptarGroup Inc | 11.00% |
| The Cooper Companies Inc | 11.54% |
| AIM ImmunoTech Inc | -10.57K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 16.28% |
| Return on Assets | 11.76% |
| Return on Invested Capital | 15.50% |
| Gross Profit Margin (Quarterly) | 98.71% |
| Operating Margin (Quarterly) | 29.71% |
| Return on Net Operating Assets | 46.54% |